An anti-interleukin-1 (anti-IL-1) alpha antibody called MABp1 has been shown to significantly improve response in patients with metastatic colorectal cancer (mCRC) in a phase III clinical trial that adopted symptom control as criteria for objective response (OR).
Regorafenib significantly improves overall survival (OS) and progression-free survival (PFS) in patients with intermediate or advanced hepatocellular carcinoma (HCC) whose disease progressed on sorafenib treatment, according to results of the phase III RESOURCE trial presented at the European Society for Medical Oncology (ESMO) 18th World Congress on Gastrointestinal Cancer.
Asia's trusted medical magazine for healthcare professionals.
Get your MIMS Pharmacist - Malaysia digital copy today!
Tacrolimus is safe and effective in inducing and maintaining remission in paediatric patients with biologic refractory inflammatory bowel disease (IBD), according to a study presented at the 49th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition in Athens, Greece.
Lifetime prevalence of acute pain leading to the use of analgesics approaches 100% in the general population, and pharmacists are a pivotal first point of contact for patients in their journey to better pain management. Noting the need for pharmacists to be more aware of their evolving role as a community pharmacist, GlaxoSmithKline Consumer Healthcare partnered with MIMS Education to organize a workshop that served as a platform for robust knowledge-sharing. Below are highlights from the workshop.